ArticleHematology, transfusion and cell therapy

Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion.

Silvia Maria Meira Magalhães et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.